Rutin is quercetin with a sugar molecule (rutinose) attached. Despite being a quercetin glycoside, it has DISTINCT pharmacological effects from quercetin because it's metabolized differently — gut bacteria must cleave the sugar to release quercetin, and the intact rutin molecule has independent anti-thrombotic and vasoprotective activities. Our research shows rutin has stronger evidence for venous insufficiency and varicose veins than quercetin, while quercetin has stronger evidence for anti-inflammatory and immune effects. Rutin is used in the Wobenzym formula specifically for its capillary-strengthening effects. Found naturally in buckwheat, citrus fruits, and asparagus.
Rutin has dual activity: (1) Intact molecule (venous system): strengthens capillary walls by reducing endothelial permeability — inhibits MMP-2/MMP-9 (enzymes that degrade vascular basement membrane); reduces edema by sealing capillary leaks; inhibits PDI on platelets (novel anti-thrombotic without bleeding risk); (2) After gut bacterial hydrolysis → quercetin (systemic): NF-κB inhibition, COX/LOX inhibition, mast cell stabilization, antioxidant. The distinction is important: rutin's venous effects are separate from quercetin's anti-inflammatory effects.
Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.